Clinical Trial

Vaccination Against Influenza Pre-discharge in Heart Failure

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 23, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
In patients with heart failure (HF), influenza vaccination should be considered to prevent HF hospitalizations. However, vaccination rates among patients with HF are low, in part because of subjective but common concerns about whether patients with such severe disease should be vaccinated. In this randomized, open-label study, we will investigate whether influenza vaccination before discharge in patients stabilized after cardiac decompensation is safe and improves outcomes over a 6-month follow-up period.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-05.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-07-18
Trial Details
NCT Number NCT06725927
Lead Sponsor Wroclaw Medical University
Conditions Heart Failure
Enrollment 200 participants
Start Date 2024-12-31
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-23